Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Founder of Shrink Nanotechnologies Named as One of the Top 35 Innovators Under 35 Worldwide by MIT Technology Review

Abstract:
Biomedical Engineer Recognized for Her Innovation in Building High Tech, Low-Cost Diagnostic Chips That Created Shrink Nanotechnologies

Shrinky Dinks Children's Toy Inspires Scientific Breakthrough

Founder of Shrink Nanotechnologies Named as One of the Top 35 Innovators Under 35 Worldwide by MIT Technology Review

Carlsbad, CA | Posted on August 25th, 2009

Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) solar energy production, (ii) medical diagnostics and sensors and (iii) biotechnology research and development tools, today announced that Dr. Michelle Khine, Ph.D., the scientific founder of Shrink's nanofabrication platform, was named by MIT Technology Review as one of the top 35 global innovators under the age of 35. The award is provided to an elite group of accomplished young innovators who exemplify the spirit of innovation and whose work spans medicine, computing, communications, nanotechnology, and more. Dr. Khine will be honored at Technology Review's EmTech09 Conference at MIT in September.

The initial iterations of Dr. Khine's innovations relied on Shrinky Dink material, sheets of thin plastic that can be colored with paint or ink and then shrunk in a hot oven. Essentially, she created a channel design for her initial devices in AutoCAD, printed it on the Shrinky Dink material, and then placed it inside a toaster oven. The heat caused the plastic to shrink and the ink particles on its surface to cluster together and form ridges. A flexible polymer - PDMS - was poured onto the surface of the cooled Shrinky Dink and the ink ridges created tiny channels in the surface of the polymer as it hardened. The PDMS was peeled back from the Shrinky Dink mold, unveiling a fully customized and functional microfluidic device that was made without the need for a clean room and millions of dollars in sensitive and expensive equipment.

The innovations recognized by the TR35 Award have ultimately become the core of what is now Shrink Nanotechnologies, the exclusive licensee of the patent-pending advances made by Dr. Khine. Shrink, with the assistance of its growing expert network of over 20 leading research scientists, has made significant improvements on its technologies and is focused on developing ultra-functional suites of products for the solar, biotech research and development, and diagnostics and sensor industries, among others.

"Discovering the amazing young men and women who make up the TR35 is one of the highlights of the year for us," said Jason Pontin, editor in chief and publisher of Technology Review. "We honor them for their achievements today and look forward to their future accomplishments."

"Dr. Michelle Khine's research has contributed to the advancement of the emerging nanotechnology industry," said Mark L. Baum, CEO of Shrink Nanotechnologies. "Shrink is utilizing Dr. Khine's technology to commercialize a broad range of applications and products such as disruptive nano-crystal solar concentrator technology. Her discoveries are the foundation of all of our product designs and will serve as the basis of a new model in the rapid design and low-cost fabrication of diagnostic chips and other nano-size devices across diverse industries, including solar energy, life sciences, and drug and chemical analysis. We congratulate Michelle on receiving this prestigious award."

Dr. Khine, a veteran entrepreneur whose first business developed into a successful VC-backed company, is a widely published researcher, with multiple patents grants and honors. She serves on several review committees, most notably the Center for Scientific Review at the National Institute of Health. She is Assistant Professor of Bioengineering and holds PhD, M.S. and B.S. degrees from the University of California Berkeley.

Additional information about past and present TR35 winners and judges is available at www.technologyreview.com/tr35/ and for details about 2009 Conference, please visit: www.technologyreview.com/emtech.

For more information about Dr. Khine's research and Shrink's technology, go to www.shrinknano.com.

####

About Shrink Nanotechnologies
Shrink is a first of its kind FIGA™ organization. FIGA companies are “for profit” businesses that bring together diverse contributions from leaders in the worlds of finance, industry, government and academia. Shrink’s solutions, including its diverse polymer substrates, nano-devices and biotech research tools, among others, are being designed to not only be ultra-function and mechanically superior in the solar energy, environmental detection, stem cell and biotechnology markets, they are also being made from biodegradable materials, including corn-based plastics. Shrink has created the ShrinkChip Manufacturing Solution™ which utilizes the unique characteristics of PolyShrink™, Shrink’s core multi-grade plastic material. Made from a unique shrinkable thermo-plastic material, PolyShrink™ enable complex ultra-functional nano-structures to be designed at the macro-scale and shrunken down, while retaining the original designs on a much smaller nano scale. This flexible and elegant design and fabrication solution reduces costs by eliminating the need for expensive clean room equipment, vastly improving time-to-market for products in Shrink’s focused market segments.

For more information, please click here

Contacts:
Brainerd Communicators
Scott Cianciulli
212-986-6667

Copyright © Businesswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

ANU invention to inspire new night-vision specs December 7th, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Possible Futures

ANU invention to inspire new night-vision specs December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Physicists decipher electronic properties of materials in work that may change transistors December 6th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

ANU invention to inspire new night-vision specs December 7th, 2016

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Journal Nanotechnology Progress International (JONPI), newest edition out December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Solar/Photovoltaic

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Throwing new light on printed organic solar cells December 1st, 2016

Physics, photosynthesis and solar cells: Researchers combine quantum physics and photosynthesis to make discovery that could lead to highly efficient, green solar cells November 30th, 2016

'Back to the Future' inspires solar nanotech-powered clothing November 15th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project